Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zhejiang Garden Bio-chemical High-tech Co Ltd
Inventory
Zhejiang Garden Bio-chemical High-tech Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
|
Inventory
¥744.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
21%
|
CAGR 10-Years
15%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Inventory
¥608.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Inventory
¥2.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
19%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Inventory
¥6.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Inventory
¥4.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Inventory
¥162.2m
|
CAGR 3-Years
25%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
Glance View
Zhejiang Garden Bio-chemical High-tech Co Ltd, nestled in the economic heart of China, boasts a robust presence in the global vitamin industry. Established with a keen focus on biosynthesis, the company has carved a niche for itself by specializing in the production of Vitamin D3. As a key player in the vitamin sector, Garden Bio-chemical uses advanced biotechnological methods to convert raw materials such as lanolin, derived from sheep's wool, into highly purified Vitamin D3. This complex process involves carefully monitored steps of extraction and fermentation, ensuring the production of high-quality vitamins that meet stringent international standards. The company’s financial health is intricately tied to its ability to meet the rising demand for vitamins across diverse markets, particularly in health-conscious segments. With the growing global emphasis on nutrition and wellness, Garden Bio-chemical capitalizes on this trend by enhancing its production capabilities and expanding its market reach. The company's revenue model relies heavily on large-scale contracts with pharmaceutical companies, dietary supplement manufacturers, and other sectors that require consistent and reliable supplies of Vitamin D3. By maintaining strong relationships with its clients and continuing to innovate in its production processes, Zhejiang Garden Bio-chemical High-tech Co Ltd ensures sustainability and profitability in an increasingly competitive market.
See Also
What is Zhejiang Garden Bio-chemical High-tech Co Ltd's Inventory?
Inventory
744.1m
CNY
Based on the financial report for Sep 30, 2025, Zhejiang Garden Bio-chemical High-tech Co Ltd's Inventory amounts to 744.1m CNY.
What is Zhejiang Garden Bio-chemical High-tech Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
15%
Over the last year, the Inventory growth was -5%. The average annual Inventory growth rates for Zhejiang Garden Bio-chemical High-tech Co Ltd have been 15% over the past three years , 21% over the past five years , and 15% over the past ten years .